Risks and benefits of nicotine to aid smoking cessation in pregnancy

Drug Safety

Volumn 24, Issue 4, 2001, Pages 277-322

  Dempsey, D A ^a   Benowitz, N L ^b  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE; NICOTINE;

BREAST FEEDING; CIGARETTE SMOKING; DRUG DISPOSITION; DRUG EFFICACY; FETUS HEART RATE; HUMAN; METABOLIC CLEARANCE RATE; PLACENTA INSUFFICIENCY; PREGNANCY; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; REVIEW; RISK BENEFIT ANALYSIS; SMOKING CESSATION; SUBSTITUTION THERAPY;

EID: 0035035774     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200124040-00005     Document Type: Review

References (340)

1. Medical-care expenditures attributable to cigarette smoking during pregnancy - United States, 1995
2. The changing cigarette
3. Pharmacology of nicotine: Addiction and therapeutics
4. Fetal nicotine or cocaine exposure: Which one is worse?
5. Pharmacokinetics, metabolism, and pharmacodynamics of nicotine
6. Accelerated N-glucuronidation of nicotine and cotinine during pregnancy
7. Accelerated nicotine and cotinine metabolism during pregnancy
8. Nicotine patch use in pregnant smokers: Nicotine and cotinine levels and fetal effects
9. Variations in cotinine levels in smokers during and after pregnancy
10. Effects of transdermal nicotine or smoking on nicotine concentrations and maternal-fetal hemodynamics
11. Transdermal nicotine replacement in pregnancy: Maternal pharmacokinetics and fetal effects
12. Saliva nicotine as an index of plasma levels in nicotine skin patch users
13. Maternal smoking and fetal breathing movements
14. Cigarette smoking and fetal breathing movements
15. Effect of nicotine on human fetal blood flow
16. Effects of short-term use of nicotine gum in pregnant smokers
17. Placental transfer and distribution of nicotine in the pregnant rhesus monkey
18. Exposure of the fetus, neonate, and nursed infant to nicotine and cotinine from maternal smokin
19. Nicotine and cotinine concentrations in serum and urine of infants exposed via passive smoking or milk from smoking mothers
20. Simultaneous fetal and maternal cotinine levels in pregnant women smokers
21. Formation and retention of cotinine during placental transfer of nicotine in human placental cotyledon
22. Fetal growth restriction
23. The maternal and fetal physiologic effects of nicotine
24. The role of ultrasound in the diagnosis and management of intrauterine growth retardation
25. Ultrasound predictors of neonatal outcome in intrauterine growth restriction
26. Diminished fetal reactivity with smoking
27. Effects of maternal cigarette smoking on ultrasonic measurements of fetal growth and on Doppler flow velocity waveforms
28. Chronic maternal cigarette smoking and fetal abdominal aortic blood flow in humans
29. Circulatory changes in the fetal aorta after maternal smoking
30. Acute effects of maternal smoking on fetal heart beat intervals
31. Acute effects of maternal smoking on fetal breathing and movements
32. Acute responses to maternal smoking of the pulsatile movements in fetal aorta
33. Acute effect of maternal smoking on the human fetal blood flow
34. Influence of nicotine chewing gum on fetal blood flow
35. Midtrimester fetal heart rate variability and maternal hemodynamics in association with smoking
36. Significant correlation between maternal hemodynamics and fetal heart rate variability
37. Effects of smoking on fetal heart rate variability during gestational weeks 27 to 32
38. Acute effects of smoking on fetal heart-rate variability
39. The acute effect of smoking on intervillous blood flow of the placenta
40. The acute effect of smoking on uteroplacental blood flow in normotensive and hypertensive pregnancy
41. Antepartum fetal heart rate variability and intervillous placental blood flow in association with smoking
42. Smoking and buccally administered nicotine. Acute effect on uterine and umbilical artery Doppler flow velocity waveforms
43. Cigarette smoking during pregnancy: Acute effects on uterine flow velocity waveforms
44. Acute effect of cigarette smoking on the fetal heart nonstress test
45. Acute metabolic and circulatory effects of cigarette smoking in late pregnancy
46. Effects of smoking on uteroplacental blood flow
47. Effects of maternal smoking on circulating catecholamine levels and fetal heart rates
48. The effect of smoking on the resistance index of the umbilical artery and the middle cerebral artery
49. Acute effects of maternal cigarette smoking on fetal heart rate and fetal body movements felt by the mother
50. Effects of maternal cigarette smoking on fetal breathing and fetal movements
51. Effects of maternal cigarette smoking on fetal trunk movements, fetal breathing movements and the fetal heart rate
52. Nicotine and caffeine. Influence on prenatal hemodynamics and behavior in early twin pregnancy
53. Maternal cigarette smoking: The effects on umbilical and uterine blood flow velocity
54. Acute effects of maternal smoking on human fetal heart function
55. Acute effect of maternal smoking on the maternal and fetal cardiovascular system
56. Effect of cigarette smoking on fetal breathing movements in normal pregnancies
57. Maternal smoking causes fetal hypoxia: Experimental evidence
58. Pharmacologic effects of nicotine upon the fetus and mother in the rhesus monkey
59. Effect of nicotine upon uterine blood flow in the pregnant rhesus monkey
60. Carboxy- and oxyhemoglobin in pregnant ewe and fetus after inhalation of marijuana, marijuana placebo and tobacco cigarette smoke
61. Some acute effects of smoking in sheep and their fetuses
62. The effect of nicotine on fetal breathing movements in conscious pregnant ewes
63. Catecholamine-mediated reduction in uterine blood flow after nicotine infusion in the pregnant ewe
64. Effect of nicotine sulfate on the hemodynamics and acid base balance of chronically instrumented pregnant sheep
65. Maternal and fetal cardiovascular effects of nicotine infusion in pregnant sheep
66. Uterine blood flow and catecholamine response to repetitive nicotine exposure in the pregnant ewe
67. Fetal hemodynamic response to maternal intravenous nicotine administration
68. Nicotine-induced changes in the cerebral circulation in ovine fetuses
69. The effect of maternal smoke exposure on the ultrastructure of fetal peripheral blood vessels in the mouse
70. The hemodynamic response of the conscious pregnant guinea pig to nicotine
71. Effects of nicotine on uterine blood flow and intrauterine oxygen tension in the rat
72. Nicotine- or epinephrine-induced uteroplacental vasoconstriction and fetal growth in the rat
73. Influence of nicotine and caffeine on rat embryonic development
74. Quantitative study of the morphofunctional changes in the placenta of rats exposed to nicotine at various periods of pregnancy
75. Fetal growth retardation due to maternal tobacco smoke exposure in the rat
76. Growth of fetuses of rats exposed to ethanol and cigarette smoke during gestation
77. Decreased birth weight and attainment of postnatal catch-up growth in offspring of rats exposed to cigarette smoke during gestation
78. Growth, development and activity in rat offspring following maternal drug exposure
79. Effects of nicotine on oviducal blood flow and embryo development in the rat
80. Effect of nicotine on the development of fetal and suckling rats
81. Effects of exposure to nicotine and to sidestream smoke on pregnancy outcome in rats
82. Fertility, maternal care, and offspring behavior in mice prenatally treated with tobacco smoke
83. Effects of prenatal exposure to cigarette smoke and nicotine on pregnancy, offspring development and avoidance behavior in rats
84. Postnatal effects of maternal nicotine exposure
85. Sex-dependent biological changes following prenatal nicotine exposure in the rat
86. The effects of prenatal nicotine on radial-arm maze performance in rats
87. Behavioral effects of prenatally administered smokeless tobacco on rat offspring
88. Behavioral effects of smokeless tobacco on the neonate and young Sprague Dawley rat
89. Voluntary activity in the aging rat as a function of maternal drug exposure
90. The effects of totigestational exposure to nicotine on pre- and postnatal development in the rat
91. Interactive effects of chronic maternal ethanol and nicotine exposure upon offspring development and function
92. Behavioral effects of prenatal exposure to nicotine in guinea pigs
93. Sex-linked differences in avoidance learning in the offspring of rats treated with nicotine during pregnancy
94. Prenatal nicotine and CNS development
95. Is nicotine depression of neonatal motor behavior exerted through ACTH release?
96. The effects of chronic prenatal exposure to nicotine on the behavior of guinea pigs (Cavia porcellus)
97. Prenatal nicotine exposure modifies behavior of mice through early development
98. A new device for monitoring early motor development: Prenatal nicotine-induced changes
99. Prenatal cocaine and/or nicotine exposure in rats: Preliminary findings on long-term cognitive outcome and genital development at birth
100. Prenatal nicotine effects on memory in rats: Pharmacological and behavioral challenges
101. Prenatal nicotine sex-dependently alters agonist-induced locomotion and stereotypy
102. Prenatal exposure to nicotine: Effects on prepulse inhibition and central nicotinic receptors
103. Postnatal behavioural effects of maternal nicotine exposure in rats
104. Perinatal administration of nicotine alters subsequent sexual behavior and testosterone levels of male rats
105. A sensitive period in gestation for nicotine acceleration of neuromuscular maturation
106. Prenatal nicotine exposure and cognitive performance in rats
107. Neonatal nicotine exposure induces permanent changes in brain nicotinic receptors and behaviour in adult mice
108. Prenatal nicotine exposure increased susceptibility to electroconvulsive shock (ECS) in adult rats
109. Alterations in hippocampal cholinergic receptors and hippocampal behaviors after early exposure to nicotine
110. Hyperactivity induced by prenatal nicotine exposure is associated with an increase in cortical nicotinic receptors
111. Effects of neonatal exposure to nicotine on electrophysiological parameters in adult rats
112. Effects of environmental tobacco smoke exposure in utero and/or postnatally on brain development
113. Maternal nicotine administration and fetal brain stem damage: A rat model with implications for sudden infant death syndrome
114. Prenatal nicotine exposure increases adrenergic receptor binding in the rat cerebral cortex
115. Nicotine administration decreases the number of binding sites and mRNA of M1 and M2 muscarinic receptors in specific brain regions of rat neonates
116. Effects of maternal nicotine injections on brain development in the rat: Ornithine decarboxylase activity, nucleic acids and proteins in discrete brain regions
117. Effects of prenatal nicotine exposure on neuronal development: Selective actions on central and peripheral catecholaminergic pathways
118. Acute stimulation of ornithine decarboxylase in neonatal rat brain regions by nicotine: A central receptor-mediated process?
119. Inhibition of DNA synthesis in neonatal rat brain regions caused by acute nicotine administration
120. Effect of maternal exposure to nicotine in the rat on level and binding of somatostatin in brain of developing offspring
121. Effects of prenatal nicotine exposure on the morphogenesis of somatosensory cortex
122. In search of a mechanism for receptor-mediated neurobehavioral teratogenesis by nicotine: Catecholamine release by nicotine in immature rat brain regions
123. Nicotine administration differentially affects gene expression in the maternal and fetal circadian clock
124. Nicotine exposure during a critical period of development leads to persistent changes in nicotinic acetylcholine receptors of adult rat brain
125. Effects of prenatal nicotine exposure on biochemical development of rat brain regions: Maternal drug infusions via osmotic minipumps
126. Development of [3H]nicotine binding sites in brain regions of rats exposed to nicotine prenatally via maternal injections or infusions
127. Prenatal exposure to nicotine via maternal infusions: Effects on development of catecholamine systems
128. Effects of prenatal nicotine exposure on rat striatal dopaminergic and nicotinic systems
129. Prenatal exposure to nicotine impairs nervous system development at a dose which does not affect viability or growth
130. Effects of acute and chronic prenatal nicotine treatment on central catecholamine systems of male and female rat fetuses and offspring
131. Effects of prenatal nicotine exposure on development of central and peripheral cholinergic neurotransmitter systems. Evidence for cholinergic trophic influences in developing brain
132. Chronic prenatal nicotine exposure sensitizes rat brain to acute postnatal nicotine challenge as assessed with ornithine decarboxylase
133. Altered development of basal and forskolin-stimulated adenylate cyclase activity in brain regions of rats exposed to nicotine prenatally
134. Fetal nicotine exposure ablates the ability of postnatal nicotine challenge to release norepinephrine from rat brain regions
135. Deficits in development of central cholinergic pathways caused by fetal nicotine exposure: Differential effects on choline acetyltransferase activity and [3H]hemicholinium-3 binding
136. Fetal nicotine exposure alters ontogeny of M1-receptors and their link to G-proteins
137. Impact of fetal nicotine exposure on development of rat brain regions: Critical sensitive periods or effects of withdrawal?
138. Hyperactivity in the offspring of nicotine-treated rats: Role of the mesolimbic and nigrostriatal dopaminergic pathways
139. Cryptic brain cell injury caused by fetal nicotine exposure is associated with persistent elevations of c-fos protooncogene expression
140. Prenatal nicotine exposure affects the development of the central serotonergic system as well as the dopaminergic system in rat offspring: Involvement of route of drug administrations
141. Exposure to prenatal nicotine transiently increases neuronal nicotinic receptor subunit alpha7, alpha4 and beta2 messenger RNAs in the postnatal rat brain
142. Prenatal nicotine exposure increased duration of nicotine-induced analgesia in adult rats
143. Effects of neonatal nicotine administration on the postnatal development of central noradrenaline neurons
144. Effects of prenatal administration of nicotine on amino acid pools, protein metabolism, and nicotine binding in the brain
145. Postnatal effects of maternal nicotine exposure on the striatal dopaminergic system in rats
146. Differential effects of prenatal and postnatal ACTH or nicotine exposure on 5-HT high affinity uptake in the neonatal rat brain
147. The teratogenic effects of nicotine in vitro in rats: A light and electron microscope study
148. Chronic nicotine treatment delays the developmental increase in brain muscarinic receptors in rat neonate
149. Ultrastructural changes in neonatal sciatic nerve tissue: Effects of passive maternal smoking
150. Development of nicotinic responses in the rat adrenal medulla and long-term effects of neonatal nicotine administration
151. Non-neurogenic adrenal catecholamine release in the neonatal rat: Exocytosis or diffusion?
152. Maturational changes in neonatal rat motor system with early postnatal administration of nicotine
153. Accelerated neuromuscular development in the rat with prenatal exposure to nicotine
154. Prenatal nicotine exposure induces cardiac adrenergic subsensitivity in adult rats
155. Fetal nicotine exposure produces postnatal up-regulation of adenylate cyclase activity in peripheral tissues
156. Prenatal nicotine exposure impairs beta-adrenergic function: Persistent chronotropic subsensitivity despite recovery from deficits in receptor binding
157. Maternal nicotine exposure enhances cutaneous axon reflexes in the neonatal rat
158. Functional and developmental studies of the peripheral arterial chemoreceptors in rat: Effects of nicotine and possible relation to sudden infant death syndrome
159. Loss of neonatal hypoxia tolerance after prenatal nicotine exposure: Implications for sudden infant death syndrome
160. Effect of nicotine exposure on postnatal ventilatory responses to hypoxia and hypercapnia
161. The cardiorespiratory response to anoxia: Normal development and the effect of nicotine
162. Impaired cardiac function during postnatal hypoxia in rats exposed to nicotine prenatally: Implications for perinatal morbidity and mortality, and for sudden infant death syndrome
163. The differential effects of exposure to tobacco smoke on the secretion of luteinizing hormone and prolactin in the proestrous rat
164. The effects of perinatal exposure to nicotine on plasma LH levels in prepubertal rats
165. Exposure to threshold doses of nicotine in utero: I. Neuroendocrine response to restraint stress in adult male offspring
166. Exposure to threshold doses of nicotine in utero: II. Neuroendocrine response to nicotine in adult male offspring
167. Exposure to threshold doses of nicotine in utero: III. Augmentation of the prolactin and ACTH response to 8-OH DPAT by desipramine treatment is compromised in adult male offspring
168. Prenatal nicotine exposure selectively affects perinatal forebrain aromatase activity and fetal adrenal function in male rats
169. Prenatal nicotine affects fetal testosterone and sexual dimorphism of saccharin preference
170. Ultrastructural changes in 9-day old mouse embryos following maternal tobacco smoke inhalation
171. Decreased fetal weights in rats exposed to sidestream cigarette smoke
172. Testing of cigarette smoke inhalation for teratogenicity in rats
173. Effects of tobacco smoke inhalation on the developing mouse embryo and fetus
174. Effect of smokeless tobacco on the development of the CD-1 mouse fetus
175. Effect of smokeless tobacco on the development of the CD-1 mouse fetus
176. Pre- and post-conceptional tobacco effects on the CD-1 mouse fetus
177. Prenatal smokeless tobacco effects on the rat fetus
178. Effects of caffeine and nicotine administration on growth and ossification of the ICR mouse fetus
179. Rat embryogenesis following exposure to alcohol and nicotine
180. Influence of nicotine and caffeine on skeletal development in the rat
181. Intrauterine development in the rat following continuous exposure to nicotine from gesrational day 6 through 12
182. Teratogenic effects of nicotine on palate formation in mice
183. Postnatal effects of nicotine on incisor development of albino mouse
184. Postnatal effects of nicotine on first molar development in the CD-1 mouse
185. Teratogenic effects of nicotine on first molar odontogenesis in the mouse
186. Effects of nicotine on murine incisor development
187. Effects of nicotine on tongue development in the CD-1 mouse
188. Tobacco smoke-induced clastogenicity in mouse fetuses and in newborn mice
189. Cigarette smoke inhalation affects the reproductive system of female hamsters
190. Cigarette smoke inhibits oocyte cumulus complex pick-up by the oviduct in vitro independent of ciliary beat frequency
191. Effect of nicotine on transferrin binding and iron uptake by cultured rat placenta
192. Nicotine and cotinine effects on development of two-cell mouse embryos in vitro
193. Ciliary beat frequency of hamster oviducts is decreased in vitro by exposure to solutions of mainstream and sidestream cigarette smoke
194. Nicotine administration to rats: Methodological considerations
195. Relationship of sudden infant death syndrome to maternal smoking during and after pregnancy
196. Passive smoking and sudden infant death syndrome: Review of the epidemiological evidence
197. Effects of carbon monoxide exposure on developing animals and humans
198. Perinatal outcome with the modified biophysical profile
199. The modified biophysical profile: Antepartum testing in the 1990s
200. A prospective analysis of the influence of gestational age on the baseline fetal heart rate and reactivity in a low risk population
201. The relationship of the nonstress test to gestational age
202. Acute effects of maternal smoking on fetal blood flow
203. Smoking during pregnancy and placental weight: A multivariate analysis on 3759 cases
204. Gross differences observed in the placentas of smokers and nonsmokers
205. Pregnancy outcome in North American women. II. Effects of diet, cigarette smoking, stress, and weight gain on placentas, and on neonatal physical and behavioral characteristics
206. Metabolism of polynuclear aromatic hydrocarbon in human term placenta influenced by cigarette smoke exposure
207. Structural changes in placental barrier of smoking mother: A quantitative and ultrastructural study
208. The influence of maternal haemoglobin and ferritin on mid-pregnancy placental volume
209. Smoking during pregnancy: The dose dependence of birthweight deficits
210. The relation of birth-weight to histological appearances in vessels of the placental bed
211. Morphometric differences between the placental vasculature of non-smokers, smokers and ex-smokers
212. Proliferation of villous trophoblast of the human placenta in normal and abnormal pregnancies
213. Multiple vascular profiles in the umbilical cord; an indication of maternal smoking habits and intrauterine distress
214. Maternal smoking inhibits early human cytotrophoblast differentiation
215. Relations of cigarette smoking and dietary antioxidants with placental calcification
216. Effect of smoking on maternal blood SPI levels in late pregnancy
217. Amniotic fluid catecholamine metabolites in maternal smoking
218. Very high collagen increase in placentae of smoking mothers
219. Effect of smoking on fibronectin production by human amnion and placenta
220. Human macrophage metalloelastase. Genomic organization, chromosomal location, gene linkage, and tissue-specific expression
221. Umbilical arteries of babies born to cigarette smokers generate less prostacyclin and contain less arginine and citrulline compared with those of babies born to control subjects
222. Placental nitric oxide metabolism
223. Effects of nicotine and nicotine/ethanol on human placental amino acids transfer
224. Placental toxicology: Tobacco smoke, abused drugs, multiple chemical interactions, and placental function
225. Transport of glycine in the brush border and basal cell membrane vesicles of the human term placenta
226. Alteration of epidermal growth factor receptor in placental membranes of smokers: Relationship with intrauterine growth retardation
227. Metabolic effects of growth factors and polycyclic aromatic hydrocarbons on cultured human placental cells of early and late gestation
228. Modulation by benzo[a]pyrene of epidermal growth factor receptors, cell proliferation, and secretion of human chorionic gonadotropin in human placental cell lines
229. Maternal serum vascular endothelial growth factor during early pregnancy
230. Smoking, human placental lactogen and birth weight
231. The effect of smoking on serum human placental lactogen levels
232. Low maternal but normal fetal prolactin levels in cigarette smoking pregnant women
233. Cotinine levels in follicular fluid and serum of IVF patients: Effect on granulosa-luteal cell function in vitro
234. Cotinine and nicotine inhibit human fetal adrenal 11 beta-hydroxylase
235. Influences of maternal smoking and fetal sex on maternal serum oestriol, prolactin, hCG, and hPI levels
236. Effect of alkaloids in cigarette smoke on human granulosa cell progesterone synthesis and cell viability
237. Lack of effect of nicotine or ethanol on the activity of 11 beta-hydroxysteroid dehydrogenase type 2
238. Effects of smoking on fetoplacental-maternal system during pregnancy
239. Human placental aromatase activity: Use of a C18 reversed-phase cartridge for separation of tritiated water or steroid metabolites in placentas from both smoking and non-smoking mothers in vitro
240. Nicotine, cotinine, and anabasine inhibit aromatase in human trophoblast in vitro
241. Tobacco smoking, pregnancy estrogens, and birth weight
242. Cigarette smoking during pregnancy lowers aromatase cytochrome P-450 in the human placenta
243. Aromatase inhibitors in cigarette smoke, tobacco leaves and other plants
244. Tobacco alkaloid derivatives as inhibitors of breast cancer aromatase
245. Effect of nicotine on production of prostacyclin in human umbilical artery
246. Reduced umbilical artery prostacyclin formation in complicated pregnancies
247. Prostaglandin metabolism in umbilical vessels of smoking and non-smoking mothers
248. Maternal smoking and prostacyclin production by cultured endothelial cells from umbilical arteries
249. Effect of cigarette smoking on plasmatic regulation of vascular prostacyclin in pregnancy and puerperium
250. Effect of nicotine on fetal prostacyclin and thromboxane in humans
251. Aggregation of and thromboxane B2 synthesis in platelets from newborn infants of smoking and non-smoking mothers
252. Maternal smoking reduces prostacyclin formation in human umbilical arteries. A study on strictly selected pregnancies
253. Prostacyclin-like activity in umbilical arteries is dose-dependently reduced by maternal smoking and related to nicotine levels
254. Urinary prostacyclin and thromboxane metabolites in drinking pregnant women and in their infants: Relations to the fetal alcohol effects
255. Maternal smoking and neonatal prostacyclin excretion
256. Smoking and preterm labor: Effect of a cigarette smoke extract on the secretion of platelet-activating factor-acetylhydrolase by human decidual macrophages
257. Secretory component of immunoglobulin A in maternal serum and the prediction of preterm delivery
258. Effect of smoking during pregnancy upon the haematological values of cord blood
259. Smoking during pregnancy-hematological observations in the newborn
260. Antepartum hematocrit, maternal smoking and birth weight
261. Maternal cigarette smoking and fetal oxygen transport: A study of P50, 2,3-diphosphoglycerate, total hemoglobin, hematocrit, and type F hemoglobin in fetal blood
262. Comparative evaluation of antepartum and postpartum platelet function in smokers and nonsmokers
263. Placental lesions and maternal hemoglobin levels. A comparative investigation
264. Relation between maternal haemoglobin and placental hormone concentrations in early pregnancy
265. Effect of smoking on ceruloplasmin and its ferroxidase activity in pregnant women
266. Elevated umbilical erythropoietin levels during labor in newborns of smoking mothers
267. Hemoconcentration in smoking mothers is associated with impaired fetal growth
268. Umbilical cord plasma erythropoietin levels in pregnancies complicated by maternal smoking
269. The pathobiology of premature rupture of membranes
270. Competitive inhibition of human placental aromatase by N-n-octanoylnornicotine and other nornicotine derivatives
271. Maternal smoking, pregnancy complications, and perinatal mortality
272. Smoking and drinking during pregnancy. Their effects on preterm birth
273. Risk factors for preterm premature rupture of the fetal membranes
274. Cigarette smoke induced functional antiprotease deficiency in the lower respiratory tract of humans
275. Effect of cigarette smoking on cervical epithelial immunity: A mechanism for neoplastic change?
276. Cigarette smoking, premature rupture of membranes, and vertical transmission of HIV-1 among women with low CD4+ levels
277. Functional evaluation of lung macrophages from cigarette smokers and nonsmokers
278. The placenta and fetal membranes
279. Ascorbic acid and transforming growth factor-b-1 increase collagen biosynthesis via different mechanisms: Coordinate regulation of pro-alpha-1 (I) and pro-alpha 1 (III) collagens
280. Ascorbic acid deficiency and premature rupture of fetal membranes
281. Ascorbic acid concentration in amniotic fluid in late pregnancy
282. The influence of smoking on vitamin C status in adults
283. Effects of ascorbate on leukocytes. Part II. Effects of ascorbic acid and calcium and sodium ascorbate on neutrophil phagocytosis and post-phagocytic metabolic activity
284. Incidence of premature rupture of membranes in pregnant women with low leukocyte levels of vitamin C
285. Premature rupture of amniotic membranes as functional assessment of vitamin C status during pregnancy
286. The relationship between cadmium, zinc, and birth weight in pregnant women who smoke
287. Cadmium levels in maternal blood, fetal cord blood, and placental tissues of pregnant women who smoke
288. Amniotic fluid cadmium and thiocyanate in pregnant women who smoke
289. Placental transfer of cadmium
290. Biological monitoring of arsenic, lead and cadmium in occupationally and environmentally exposed pregnant women
291. The effect of smoking on placental and fetal zinc status
292. Associations between placental cadmium and zinc and age and parity in pregnant women who smoke
293. Smoking alters the relationship between maternal zinc intake and biochemical indices of fetal zinc status
294. The relationship between placental cadmium, zinc, and copper
295. Regulation of metallothionein expression in human amnion epithelial and mesenchymal cells
296. Cadmium selectively inhibits fibroblast procollagen production and proliferation
297. Preterm birth
298. Detection of fetal fibronectin as a predictor of preterm delivery in high risk symptomatic pregnancies
299. Cigarette smoke extract inhibits fibroblast-mediated collagen gel contraction
300. Tobacco smoking by pregnant women. Disturbances in metabolism of branched chain amino acids and fetal growth
301. The molecular mechanisms of term and preterm labor: Recent progress and clinical implications
302. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults
303. A multicenter, prospective study of fetal outcome following accidental carbon monoxide poisoning in pregnancy
304. Is carbon monoxide a workplace teratogen? A review and evaluation of the literature
305. Hematologic principles
306. Carboxyhemoglobin concentration in fetal cord blood and in blood of mothers who smoked during labor
307. The biological effects of carbon monoxide on the pregnant woman, fetus, and newborn infant
308. Smoking during pregnancy and its effects on the fetus
309. Cigarette smoking in pregnancy and fetal hyperviscosity
310. Haematologic parameters and pregnancy outcome. A prospective cohort study in the third trimester
311. Carbon monoxide: Effects on oxygenation of the fetus in utero
312. Oxygen transport and delivery
313. Respiratory function of hemoglobin
314. Chronic low level maternal carbon monoxide exposure and fetal growth and development
315. Placental growth in rats exposed to carbon monoxide at selected stages of pregnancy
316. Alteration in the postnatal ontogeny of cerebellar norepinephrine content following chronic prenatal carbon monoxide
317. Prenatal carbon monoxide exposure differentially affects postnatal weight and monoamine concentration of rat brain regions
318. Postnatal alterations in cerebellar GABA content, GABA uptake and morphology following exposure to carbon monoxide early in development
319. Ornithine decarboxylase activity in fetal and newborn rat brain: Responses to hypoxia and carbon monoxide hypoxia
320. Changes in peripheral nervous system activity produced in rats by prenatal exposure to carbon monoxide
321. Wallerian degeneration in rat sciatic nerve comparative evaluation between prenatal and postnatal exposure to carbon monoxide
322. Effects on the offspring of chronic low exposure carbon monoxide during mice pregnancy
323. Early behavioral alterations in mice following prenatal carbon monoxide exposure
324. Toxicity of mild prenatal carbon monoxide exposure
325. Effects of prenatal carbon monoxide exposure on neonatal rats
326. Prenatal carbon monoxide exposure alters behavioral development
327. Prenatal exposure to carbon monoxide: Learning and memory deficits
328. Moderate prenatal carbon monoxide exposure produces persistent, and apparently permanent, memory deficits in rats
329. The cardiac response of the fetal rat to carbon monoxide exposure
330. Cardiomegaly in neonatal rats exposed to 500 ppm carbon monoxide
331. Cardiomegaly due to myocyte hyperplasia in perinatal rats exposed to 200 ppm carbon monoxide
332. Effect of littersize (i.e., nutrition) on carbon monoxide-induced persistent heart changes
333. Toxicity of carbon monoxide: Hemoglobin vs. histotoxic mechanisms
334. Carbon monoxide: From tool to neurotransmitter
335. Carbon monoxide, a putative neural messenger
336. Carbon monoxide: A role in carotid body chemoreception
337. Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy
338. Stable isotope studies of nicotine kinetics and bioavailability
339. Nicotine and cotinine concentrations in the nursing mother and her infant